However, contrary to the latter, Oropesa et al. demonstrated that, during apoptosis in alvaxanthone-treated glioblastoma cells, the level of ATP was unchanged or even increased during early phases of apoptosis, despite caspase 3 and 7 undergoing activation [47]. The gene discussed is CASP3; the disease is glioblastoma.